Age-associated impairment in TNF-α cardioprotection from myocardial infarction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 2 54-2, 2003, Pages

  Cai, Dongqing ^a   Xaymardan, Munira ^a   Holm, Jacquelyne M ^a   Zheng, Jingang ^a   Kizer, Jorge R ^a   Edelberg, Jay M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Aging; Endothelial; Functional genomics; Heart; Phage display

Indexed keywords

PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR B; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

AGING; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENOMICS; HEART INFARCTION; HEART PROTECTION; MICROVASCULATURE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

EID: 0038638371     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00144.2003     Document Type: Article

References (44)

1. Aggarwal S, Gollapudi S, and Gupta S. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J Immunol 162: 2154-2161, 1999.
2. American Heart Association. Americans and cardiovascular disease biostatistical fact sheet. Older Americans and Cardiovascular Disease. Dallas, TX: American Heart Association, 2001.
3. Anderson KM, Califf RM, Stone GW, Neumann FJ, Montalescot G, Miller DP, Ferguson JJ 3rd, Willerson JT, Weisman HF, and Topol EJ. Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 37: 2059-2065, 2001.
4. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, and Pedersen BK. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 54: M357-M364, 1999.
5. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, and Giroir B. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97: 1375-1381, 1998.
6. Carcamo J, Ravera MW, Brissette R, Dedova O, Beasley JR, Alam-Moghe A, Wan C, Blume A, and Mandecki W. Unexpected frameshifts from gene to expressed protein in a phage-displayed peptide library. Proc Natl Acad Sci USA 95: 11146-11151, 1998.
7. Dong QG, Bernasconi S, Lostaglio S, De Calmanovici RW, Martin-Padura I, Breviario F, Garlanda C, Ramponi S, Mantovani A, and Vecchi A. A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler Thromb Vasc Biol 17: 1599-1604, 1997.
8. Dorge H, Schulz R, Belosjorow S, Post H, van de Sand A, Konietzka I, Frede S, Hartung T, Vinten-Johansen J, Youker KA, Entman ML, Erbel R, and Heusch G. Coronary microembolization: the role of TNF-alpha in contractile dysfunction. J Mol Cell Cardiol 34: 51-62, 2002.
9. Eddy LJ, Goeddel DV, and Wong GH. Tumor necrosis factor-alpha pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 184: 1056-1059, 1992.
10. Edelberg JM, Lee SH, Kaur M, Tang L, Feirt NM, McCabe S, Bramwell O, Wong SC, and Hong MK. Platelet-derived growth factor-AB limits the extent of myocardial infarction in a rat model: feasibility of restoring impaired angiogenic capacity in the aging heart. Circulation 105: 608-613, 2002.
11. Franco F, Thomas GD, Giroir B, Bryant D, Bullock MC, Chwialkowski MC, Victor RG, and Peshock RM. Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 99: 448-454, 1999.
12. Funayama H, Ikeda U, Takahashi M, Sakata Y, Kitagawa S, Takahashi Y, Masuyama J, Furukawa Y, Miura Y, Kano S, Matsuda M, and Shimada K. Human monocyte-endothelial cell interaction induces platelet-derived growth factor expression. Cardiovasc Res 37: 216-224, 1998.
13. Goldman E, Korus M, and Mandecki W. Efficiencies of translation in three reading frames of unusual non-ORF sequences isolated from phage display. FASEB J 14: 603-611, 2000.
14. Gupta S. Tumor necrosis factor-alpha-induced apoptosis in T cells from aged humans: a role of TNFR-I and downstream signaling molecules. Exp Gerontol 37: 293-299, 2002.
15. Hajjar KA, Hajjar DP, Silverstein RL, and Nachman RL. Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med 166: 235-245, 1987.
16. Hayder H, Blanden RV, Korner H, Riminton DS, Sedgwick JD, and Mullbacher A. Adenovirus-induced liver pathology is mediated through TNF receptors I and II but is independent of TNF or lymphotoxin. J Immunol 163: 1516-1520, 1999.
17. Hoffmann J, Haendeler J, Aicher A, Rossig L, Vasa M, Zeiher AM, and Dimmeler S. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 89: 709-715, 2001.
18. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, and Mann DL. Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 96: 1042-1052, 1995.
19. Kurrelmeyer KM, Michael LH, Baumgarten G, Taffet GE, Peschon JJ, Sivasubramanian N, Entman ML, and Mann DL. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci USA 97: 5456-5461, 2000.
20. Liu L, Azhar G, Gao W, Zhang X, and Wei JY. Bcl-2 and Bax expression in adult rat hearts after coronary occlusion: age-associated differences. Am J Physiol Regul Integr Comp Physiol 275: R315-R322, 1998.
21. Liu ZX, Govindarajan S, Okamoto S, and Dennert G. Fas- and tumor necrosis factor receptor 1-dependent but not perfor-independent pathways cause injury in livers infected with an adenovirus construct in mice. Hepatology 31: 665-673, 2000.
22. Miki K and Eddy EM. Tumor necrosis factor receptor 1 is an ATPase regulated by silencer of death domain. Mol Cell Biol 22: 2536-2543, 2002.
23. Montrucchio G, Lupia E, Battaglia E, Passerini G, Bussolino F, Emanuelli G, and Camussi G. Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J Exp Med 180: 377-382, 1994.
24. Nakano M, Knowlton AA, Dibbs Z, and Mann DL. Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte. Circulation 97: 1392-1400, 1998.
25. Nelson SK, Wong GH, and McCord JM. Leukemia inhibitory factor and tumor necrosis factor induce manganese superoxide dismutase and protect rabbit hearts from reperfusion injury. J Mol Cell Cardiol 27: 223-229, 1995.
26. Nishida M, Springhorn JP, Kelly RA, and Smith TW. Cell-cell signaling between adult rat ventricular myocytes and cardiac microvascular endothelial cells in heterotypic primary culture. J Clin Invest 91: 1934-1941, 1993.
27. Okamura T, Miura T, Takemura G, Fujiwara H, Iwamoto H, Kawamura S, Kimura M, Ikeda Y, Iwatate M, and Matsuzaki M. Effect of caspase inhibitors on myocardial infarct size and myocyte DNA fragmentation in the ischemia-reperfused rat heart. Cardiovasc Res 45: 642-650, 2000.
28. Paolisso G, Rizzo MR, Mazziotti G, Tagliamonte AM, Gambardella A, Rotondi M, Carella C, Giugliano D, Varricchio M, and D'Onofrio F. Advancing age and insulin resistance: role of plasma tumor necrosis factor-α. Am J Physiol Endocrinol Metab 275: E294-E299, 1998.
29. Paul SD, O'Gara PT, Mahjoub ZA, DiSalvo TG, O'Donnell CJ, Newell JB, Villarreal-Levy G, Smith AJ, Kondo NI, Cararach M, Ferrer L, and Eagle KA. Geriatric patients with acute myocardial infarction: cardiac risk factor profiles, presentation, thrombolysis, coronary interventions, and prognosis. Am Heart J 131: 710-715, 1996.
30. Raya TE, Gaballa M, Anderson P, and Goldman S. Left ventricular function and remodeling after myocardial infarction in aging rats. Am J Physiol Heart Circ Physiol 273: H2652-H2658, 1997.
31. Rice PL, Porter SE, Koski KM, Ramakrishna G, Chen A, Schrump D, Kazlauskas A, and Malkinson AM. Reduced receptor expression for platelet-derived growth factor and epidermal growth factor in dividing mouse lung epithelial cells. Mol Carcinog 25: 285-294, 1999.
32. Rich M, Bosner M, Chung M, Shen J, and McKenzie J. Is age an independent predictor of early and late mortality in patients with acute myocardial infarction? Am J Med 92: 7-13, 1992.
33. Schachinger V, Britten MB, and Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101: 1899-1906, 2000.
34. Shiraha H, Gupta K, Drabik K, and Wells A. Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors. J Biol Chem 275: 19343-19351, 2000.
35. Smith RM, Suleman N, McCarthy J, and Sack MN. Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene. Cardiovasc Res 55: 553-560, 2002.
36. Spyridopoulos I, Brogi E, Kearney M, Sullivan AB, Cetrulo C, Isner JM, and Losordo DW. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals. J Mol Cell Cardiol 29: 1321-1330, 1997.
37. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, and Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101: 948-954, 2000.
38. Tahepold P, Valen G, Starkopf J, Ceslava K, Ailmer M, and Vaage J. Pretreating rats with hyperoxia attenuates ischemia-reperfusion injury of the heart. Life Sci 68: 1629-1640, 2001.
39. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, and Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 92: 1487-1493, 1995.
40. Turner JR, Liu L, Fligiel SE, Jaszewski R, and Majumdar AP. Aging alters gastric mucosal responses to epidermal growth factor and transforming growth factor-α. Am J Physiol Gastrointest Liver Physiol 278: G805-G810, 2000.
41. Weinsaft JW and Edelberg JM. Aging-associated changes in vascular activity-a potential link to geriatric cardiovascular disease. Am J Geriatric Cardiol 10: 348-354, 2001.
42. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, and Kuwano M. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 17: 4015-4023, 1997.
43. Zhang HG, Xie J, Xu L, Yang P, Xu X, Sun S, Wang Y, Curiel DT, Hsu HC, and Mountz JD. Hepatic DR5 induces apoptosis and limits adenovirus gene therapy product expression in the liver. J Virol 76: 5692-5700, 2002.
44. Zhang Y, Pasparakis M, Kollias G, and Simons M. Myocyte-dependent regulation of endothelial cell syndecan-4 expression. Role of TNF-alpha. J Biol Chem 274: 14786-14790, 1999.